These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1049 related items for PubMed ID: 27692533

  • 1. 18FDG-PET-CT improves specificity of preoperative lymph-node staging in patients with intestinal but not diffuse-type esophagogastric adenocarcinoma.
    Lehmann K, Eshmuminov D, Bauerfeind P, Gubler C, Veit-Haibach P, Weber A, Abdul-Rahman H, Fischer M, Reiner C, Schneider PM.
    Eur J Surg Oncol; 2017 Jan; 43(1):196-202. PubMed ID: 27692533
    [Abstract] [Full Text] [Related]

  • 2. FDG-PET/CT lymph node staging after neoadjuvant chemotherapy in patients with adenocarcinoma of the esophageal-gastric junction.
    Fencl P, Belohlavek O, Harustiak T, Zemanova M.
    Abdom Radiol (NY); 2016 Nov; 41(11):2089-2094. PubMed ID: 27405645
    [Abstract] [Full Text] [Related]

  • 3. Siewert type I and II oesophageal adenocarcinoma: sensitivity/specificity of computed tomography, positron emission tomography and endoscopic ultrasound for assessment of lymph node metastases in groups of thoracic and abdominal lymph node stations.
    Lopci E, Kauppi J, Lugaresi M, Mattioli B, Daddi N, Fortunato F, Rasanen J, Mattioli S.
    Interact Cardiovasc Thorac Surg; 2019 Apr 01; 28(4):518-525. PubMed ID: 30496443
    [Abstract] [Full Text] [Related]

  • 4. Prospective analysis of accuracy of positron emission tomography, computed tomography, and endoscopic ultrasonography in staging of adenocarcinoma of the esophagus and the esophagogastric junction.
    Räsänen JV, Sihvo EI, Knuuti MJ, Minn HR, Luostarinen ME, Laippala P, Viljanen T, Salo JA.
    Ann Surg Oncol; 2003 Oct 01; 10(8):954-60. PubMed ID: 14527917
    [Abstract] [Full Text] [Related]

  • 5. Adenocarcinoma of the esophagus and the esophagogastric junction: positron emission tomography improves staging and prediction of survival in distant but not in locoregional disease.
    Sihvo EI, Räsänen JV, Knuuti MJ, Minn HR, Luostarinen ME, Viljanen T, Färkkilä MA, Salo JA.
    J Gastrointest Surg; 2004 Dec 01; 8(8):988-96. PubMed ID: 15585386
    [Abstract] [Full Text] [Related]

  • 6. Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the esophagus and gastroesophageal junction: A prospective study based on primary surgery with extensive lymphadenectomy.
    Lerut T, Flamen P, Ectors N, Van Cutsem E, Peeters M, Hiele M, De Wever W, Coosemans W, Decker G, De Leyn P, Deneffe G, Van Raemdonck D, Mortelmans L.
    Ann Surg; 2000 Dec 01; 232(6):743-52. PubMed ID: 11088069
    [Abstract] [Full Text] [Related]

  • 7. Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography.
    Chen J, Cheong JH, Yun MJ, Kim J, Lim JS, Hyung WJ, Noh SH.
    Cancer; 2005 Jun 01; 103(11):2383-90. PubMed ID: 15856477
    [Abstract] [Full Text] [Related]

  • 8. Comparison between 18F-FDG PET/MRI and MDCT for the assessment of preoperative staging and resectability of gastric cancer.
    Lee DH, Kim SH, Joo I, Hur BY, Han JK.
    Eur J Radiol; 2016 Jun 01; 85(6):1085-91. PubMed ID: 27161056
    [Abstract] [Full Text] [Related]

  • 9. [Positron emission tomography for preoperative lymph node diagnosis in esophageal carcinoma].
    Kneist W, Schreckenberger M, Bartenstein P, Grünwald F, Oberholzer K, Junginger T.
    Chirurg; 2003 Oct 01; 74(10):922-30; discussion 929-30. PubMed ID: 14605734
    [Abstract] [Full Text] [Related]

  • 10. Value of regular endosonography and [18F]fluorodeoxyglucose PET-CT after surgery for gastro-oesophageal junction, stomach or pancreatic cancer.
    Bjerring OS, Hess S, Petersen H, Fristrup CW, Lundell L, Mortensen MB.
    BJS Open; 2021 Mar 05; 5(2):. PubMed ID: 33688946
    [Abstract] [Full Text] [Related]

  • 11. The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma.
    Kato H, Miyazaki T, Nakajima M, Takita J, Kimura H, Faried A, Sohda M, Fukai Y, Masuda N, Fukuchi M, Manda R, Ojima H, Tsukada K, Kuwano H, Oriuchi N, Endo K.
    Cancer; 2005 Jan 01; 103(1):148-56. PubMed ID: 15558794
    [Abstract] [Full Text] [Related]

  • 12. Fluorine-18 fluorodeoxyglucose positron emission tomography in the preoperative staging of thoracic oesophageal and gastro-oesophageal junction cancer: a prospective study.
    Katsoulis IE, Wong WL, Mattheou AK, Damani N, Chambers J, Livingstone JI.
    Int J Surg; 2007 Dec 01; 5(6):399-403. PubMed ID: 17631431
    [Abstract] [Full Text] [Related]

  • 13. Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma.
    Flamen P, Lerut A, Van Cutsem E, De Wever W, Peeters M, Stroobants S, Dupont P, Bormans G, Hiele M, De Leyn P, Van Raemdonck D, Coosemans W, Ectors N, Haustermans K, Mortelmans L.
    J Clin Oncol; 2000 Sep 15; 18(18):3202-10. PubMed ID: 10986052
    [Abstract] [Full Text] [Related]

  • 14. Lymph node staging of gastric cancer using (18)F-FDG PET: a comparison study with CT.
    Yun M, Lim JS, Noh SH, Hyung WJ, Cheong JH, Bong JK, Cho A, Lee JD.
    J Nucl Med; 2005 Oct 15; 46(10):1582-8. PubMed ID: 16204706
    [Abstract] [Full Text] [Related]

  • 15. Endoscopic ultrasound-guided fine needle aspiration of mediastinal lymph node in patients with suspected lung cancer after positron emission tomography and computed tomography scans.
    Eloubeidi MA, Cerfolio RJ, Chen VK, Desmond R, Syed S, Ojha B.
    Ann Thorac Surg; 2005 Jan 15; 79(1):263-8. PubMed ID: 15620955
    [Abstract] [Full Text] [Related]

  • 16. Role of positron emission tomography in the (re-)staging of oesophageal cancer.
    Westerterp M, Van Westreenen HL, Sloof GW, Plukker JT, Van Lanschot JJ.
    Scand J Gastroenterol Suppl; 2006 Jan 15; (243):116-22. PubMed ID: 16782630
    [Abstract] [Full Text] [Related]

  • 17. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.
    Jensen TK, Holt P, Gerke O, Riehmann M, Svolgaard B, Marcussen N, Bouchelouche K.
    Scand J Urol Nephrol; 2011 Mar 15; 45(2):122-8. PubMed ID: 21231796
    [Abstract] [Full Text] [Related]

  • 18. The Prognostic Role of Pre-operative Positron Emission Tomography-Computed Tomography and Endoscopic Ultrasound Parameters in Oesophageal Adenocarcinoma.
    Dellaportas D, Zylstra J, Gossage J, Baker C, Kelly M, Hemelrijck MV, Griffin N, Lagergren J, Davies AR.
    Chirurgia (Bucur); 2019 Mar 15; 114(4):443-450. PubMed ID: 31511130
    [Abstract] [Full Text] [Related]

  • 19. Lymph node staging in esophageal adenocarcinoma with PET-CT based on a visual analysis and based on metabolic parameters.
    Roedl JB, Blake MA, Holalkere NS, Mueller PR, Colen RR, Harisinghani MG.
    Abdom Imaging; 2009 Mar 15; 34(5):610-7. PubMed ID: 18830663
    [Abstract] [Full Text] [Related]

  • 20. A prospective evaluation of the utility of 2-deoxy-2-[(18) F]fluoro-D-glucose positron emission tomography and computed tomography in staging locally advanced gastric cancer.
    Smyth E, Schöder H, Strong VE, Capanu M, Kelsen DP, Coit DG, Shah MA.
    Cancer; 2012 Nov 15; 118(22):5481-8. PubMed ID: 22549558
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.